Arecor is leveraging this unique formulation platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides.
Diabetes is a chronic condition that affects the body’s ability to control blood sugar level. If left untreated it can lead to serious health complications.
Significantly faster onset of action
Improved glycemic control
Desired advancement for artificial pancreas
No stable aqueous glucagon currently available
Ready to use pen to treat severe hypoglycemia
Critical unmet need for bi-hormonal artificial pancreas
Critical for miniaturisation of delivery devices
Superior fast acting insulin for high dose users